Palisade Bio (PALI) Net Income (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.67% |
| Dec 31, 2025 | -241.07% |
| Sep 30, 2025 | -2.88% |
| Jun 30, 2025 | -23.11% |
| Mar 31, 2025 | 31.73% |
| Dec 31, 2024 | 5.95% |
| Sep 30, 2024 | 14.57% |
| Jun 30, 2024 | -14.67% |
| Mar 31, 2024 | -16.34% |
| Dec 31, 2023 | 16.59% |
| Sep 30, 2023 | -4.82% |
| Jun 30, 2023 | -42.82% |
| Mar 31, 2023 | 34.33% |
| Dec 31, 2022 | 12.81% |
| Sep 30, 2022 | -23.48% |
| Jun 30, 2022 | 8.02% |
| Mar 31, 2022 | 3.55% |
| Dec 31, 2021 | -32.54% |
| Sep 30, 2021 | 90.92% |
| Jun 30, 2021 | -815.38% |
| Mar 31, 2021 | -6.57% |
| Dec 31, 2020 | -87.09% |
| Sep 30, 2020 | 0.34% |
| Jun 30, 2020 | 6.93% |
| Mar 31, 2020 | 6.81% |
| Dec 31, 2019 | -0.64% |
| Sep 30, 2019 | -10.63% |
| Jun 30, 2019 | 21.47% |
| Mar 31, 2019 | -36.15% |
| Dec 31, 2018 | 13.65% |
| Sep 30, 2018 | -3.11% |
| Jun 30, 2018 | 14.10% |
| Mar 31, 2018 | -3.47% |
| Dec 31, 2017 | 12.30% |
| Sep 30, 2017 | 39.07% |
| Jun 30, 2017 | 2.99% |
| Mar 31, 2017 | 25.35% |
| Dec 31, 2016 | -13.36% |
| Sep 30, 2016 | -24.06% |
| Jun 30, 2016 | 37.31% |
| Mar 31, 2016 | -38.41% |
| Dec 31, 2015 | 15.30% |
| Sep 30, 2015 | -3.68% |
| Jun 30, 2015 | -7.61% |
| Mar 31, 2015 | 0.08% |
| Dec 31, 2014 | -13.52% |
| Sep 30, 2014 | -14.49% |
| Jun 30, 2014 | 30.32% |
| Mar 31, 2014 | -74.65% |
| Dec 31, 2013 | 21.32% |
| Sep 30, 2013 | -11.10% |
| Jun 30, 2013 | -24.85% |
| Mar 31, 2013 | -7.92% |
| Dec 31, 2012 | -5.32% |
| Sep 30, 2012 | -8.49% |
| Jun 30, 2012 | 3.22% |
| Mar 31, 2012 | 3.95% |
| Dec 31, 2011 | 20.40% |
| Sep 30, 2011 | 11.98% |
| Jun 30, 2011 | -3.85% |
| Mar 31, 2011 | -131.35% |
| Dec 31, 2010 | 61.12% |
| Sep 30, 2010 | 6.69% |